Every few months a new analysis lands with the same headline: launch prices for new drugs outpace inflation. The latest reported that the median net launch price for 154 medicines rose 51 percent from ...

In 2020, the Federal Reserve (the Fed) responded to an acute recession by cutting interest rates and launching large-scale asset purchases to support credit and stimulate demand. Then, inflation in ...

According to the National Corn Growers Association, when historical costs to grow corn are indexed to 2025 dollars, there are two historical periods in which costs have been relatively higher than the ...

Ed Silverman, a senior writer and Pharmalot columnist at STAT, has been covering the pharmaceutical industry for nearly three decades. He is also the author of the morning Pharmalittle newsletter and ...

The annual launch price of novel treatments approved from 2022 to 2024 continued to rise significantly in the U.S., exceeding the rate of inflation and GDP growth, a new report from the drug pricing ...